Hochschulschrift
Combinations of costimulatory antibody-ligand fusion proteins for targeted cancer immunotherapy
- Weitere Titel
-
Kombinationen von kostimulatorischen Antikörper-Ligand-Fusionsproteinen für eine zielgerichtete Tumorimmuntherapie
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Stuttgart, Universität Stuttgart, Diss., 2013
- Schlagwort
-
Tumor ; Immuntherapie
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Stuttgart
- (wer)
-
Universitätsbibliothek der Universität Stuttgart
- (wann)
-
2013
- Urheber
- Beteiligte Personen und Organisationen
-
Kontermann, Roland
- URN
-
urn:nbn:de:bsz:93-opus-87497
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:57 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Hornig, Nora
- Kontermann, Roland
- Universitätsbibliothek der Universität Stuttgart
Entstanden
- 2013
Ähnliche Objekte (12)
Dual Antigen-Restricted Complementation of a Two-Part Trispecific Antibody for Targeted Immunotherapy of Blood Cancer
Targeted gene transfer to enhance safety and efficacy of immunotherapy
Increasing the Traceability Through Targeted Data Acquisition for Given Product Process Combinations
Antibody masked cytokines as new approach in targeted tumor therapy
Targeted Phagocytosis Induction for Cancer Immunotherapy via Bispecific MerTK-Engaging Antibodies
Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy
Functional characterization of Fas ligand on tumor cells escaping active specific immunotherapy
The HLA Ligand Atlas. Defining Actionable Targets For T-Cell-Based Immunotherapy
Identification of synergistic combinations of targeted cytostatic drugs and immunostimulatory antibodies in preclinical models
Combinations-Linien.
Forecast combinations
Combinations Tabel
Dual Antigen-Restricted Complementation of a Two-Part Trispecific Antibody for Targeted Immunotherapy of Blood Cancer
Targeted gene transfer to enhance safety and efficacy of immunotherapy
Increasing the Traceability Through Targeted Data Acquisition for Given Product Process Combinations
Antibody masked cytokines as new approach in targeted tumor therapy
Targeted Phagocytosis Induction for Cancer Immunotherapy via Bispecific MerTK-Engaging Antibodies
Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy
Functional characterization of Fas ligand on tumor cells escaping active specific immunotherapy
The HLA Ligand Atlas. Defining Actionable Targets For T-Cell-Based Immunotherapy
Identification of synergistic combinations of targeted cytostatic drugs and immunostimulatory antibodies in preclinical models
Combinations-Linien.
Forecast combinations
Combinations Tabel
Dual Antigen-Restricted Complementation of a Two-Part Trispecific Antibody for Targeted Immunotherapy of Blood Cancer
Targeted gene transfer to enhance safety and efficacy of immunotherapy
Increasing the Traceability Through Targeted Data Acquisition for Given Product Process Combinations
Antibody masked cytokines as new approach in targeted tumor therapy
Targeted Phagocytosis Induction for Cancer Immunotherapy via Bispecific MerTK-Engaging Antibodies
Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy
Functional characterization of Fas ligand on tumor cells escaping active specific immunotherapy
The HLA Ligand Atlas. Defining Actionable Targets For T-Cell-Based Immunotherapy
Identification of synergistic combinations of targeted cytostatic drugs and immunostimulatory antibodies in preclinical models
Combinations-Linien.
Forecast combinations